Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Pathogenesis Of NSAID-induced Gastric Damage: Importance Of Cyclooxygenase Inhibition And Gastric Hypermotility.

K. Takeuchi
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This article reviews the pathogenic mechanism of non-steroidal anti-inflammatory drug (NSAID)-induced gastric damage, focusing on the relation between cyclooxygenase (COX) inhibition and various functional events. NSAIDs, such as indomethacin, at a dose that inhibits prostaglandin (PG) production, enhance gastric motility, resulting in an increase in mucosal permeability, neutrophil infiltration and oxyradical production, and eventually producing gastric lesions. These lesions are prevented by pretreatment with PGE₂ and antisecretory drugs, and also via an atropine-sensitive mechanism, not related to antisecretory action. Although neither rofecoxib (a selective COX-2 inhibitor) nor SC-560 (a selective COX-1 inhibitor) alone damages the stomach, the combined administration of these drugs provokes gastric lesions. SC-560, but not rofecoxib, decreases prostaglandin E₂ (PGE₂) production and causes gastric hypermotility and an increase in mucosal permeability. COX-2 mRNA is expressed in the stomach after administration of indomethacin and SC-560 but not rofecoxib. The up-regulation of indomethacin-induced COX-2 expression is prevented by atropine at a dose that inhibits gastric hypermotility. In addition, selective COX-2 inhibitors have deleterious influences on the stomach when COX-2 is overexpressed under various conditions, including adrenalectomy, arthritis, and Helicobacter pylori-infection. In summary, gastric hypermotility plays a primary role in the pathogenesis of NSAID-induced gastric damage, and the response, causally related with PG deficiency due to COX-1 inhibition, occurs prior to other pathogenic events such as increased mucosal permeability; and the ulcerogenic properties of NSAIDs require the inhibition of both COX-1 and COX-2, the inhibition of COX-1 upregulates COX-2 expression in association with gastric hypermotility, and PGs produced by COX-2 counteract the deleterious effect of COX-1 inhibition.
This paper references
10.1111/J.2042-7158.1973.TB09953.X
Ulcerogenic potential of indomethacin in arthritic and non‐arthritic rats
G. Dipasquale (1973)
10.1124/JPET.300.3.754
Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
A. Tanaka (2002)
10.1163/156856002321544882
Selective cyclooxygenase-2 inhibitor induces gastric mucosal damage in adrenalectomized rats
L. Filaretova (2004)
10.1073/PNAS.96.11.6377
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.
B. Cronstein (1999)
10.1007/s10620-006-9394-8
Preconditioning Stress Prevents Cold Restraint Stress-Induced Gastric Lesions in Rats: Roles of COX-1, COX-2, and PLA2
A. Tanaka (2006)
10.1074/JBC.M502956200
Involvement of Intracellular Ca2+ Levels in Nonsteroidal Anti-inflammatory Drug-induced Apoptosis*
K. Tanaka (2005)
10.1136/gut.45.4.523
Indomethacin induced gastropathy in CD18, intercellular adhesion molecule 1, or P-selectin deficient mice
Z. Morise (1999)
10.1074/jbc.M111.279893
Translocation of Heme Oxygenase-1 to Mitochondria Is a Novel Cytoprotective Mechanism against Non-steroidal Anti-inflammatory Drug-induced Mitochondrial Oxidative Stress, Apoptosis, and Gastric Mucosal Injury*
S. Bindu (2011)
10.1053/j.gastro.2008.05.030
Gastric mucosal defense and cytoprotection: bench to bedside.
L. Laine (2008)
10.1007/BF01535735
Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats
S. Ueki (2005)
restraint-induced lesion formation in rats
K Takeuchi (1986)
modynamics and gastric motility
A Anthony (1990)
10.1111/j.1440-1746.1997.tb00443.x
Analysis of pathogenic elements involved in gastric lesions induced by non‐steroidal anti‐inflammatory drugs in rats
K. Takeuchi (1997)
10.1016/0092-8674(95)90126-4
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
R. Langenbach (1995)
Involvement of intracellular Ca levels in nonsteroidal antiinflammatory drug-induced apoptosis
M Aburaya (2005)
10.1016/0090-6980(81)90130-1
Gastric cytoprotection by sodium salicylate.
A. Robert (1981)
10.1124/jpet.102.041715
Role of Cyclooxygenase (COX)-1 and COX-2 Inhibition in Nonsteroidal Anti-Inflammatory Drug-Induced Intestinal Damage in Rats: Relation to Various Pathogenic Events
A. Tanaka (2002)
10.1124/jpet.107.122978
Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) Benzoic Acid (CJ-42794), a Selective Antagonist of Prostaglandin E Receptor Subtype 4, on Ulcerogenic and Healing Responses in Rat Gastrointestinal Mucosa
K. Takeuchi (2007)
The relationship between serum gastrin, gastric ulceration and basal acid output in the polyarthritic rat.
P. Mathur (1980)
10.1016/S0002-9440(10)65343-6
Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils.
T. Ikeno (1999)
[Effect of acetylsalicylic and 2,3-dihydroxybenzoic acids on liver mitochondrial respiration in rats].
M. D. Cherkasskaia (1976)
10.1016/0016-5085(89)90063-2
Bilateral adrenalectomy worsens gastric mucosal lesions induced by indomethacin in the rat. Role of enhanced gastric motility.
K. Takeuchi (1989)
10.1016/0016-5085(81)90196-7
Temporal Relationship Between Cyclooxygenase Inhibition, as Measured by Prostacyclin Biosynthesis, and the Gastrointestinal Damage Induced by Indomethacin in the Rat
B. Whittle (1981)
10.1046/j.1365-2036.2000.014s1116.x
The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach
H. Araki (2000)
10.1016/0016-5085(89)91563-1
Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin.
J. Y. Wang (1989)
10.1007/BF02220462
Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat
R. Melarange (2005)
10.1152/AJPGI.00525.2002
Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
M. Souza (2003)
10.1073/PNAS.87.4.1620
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
J. Beckman (1990)
neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats
S Suemasu (2000)
10.1152/AJPGI.00137.2003
Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
T. Tanigawa (2004)
10.1046/j.1365-2036.1999.00548.x
Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide
S. Kato (1999)
10.1053/GAST.2000.16510
NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
J. Wallace (2000)
10.1097/00004836-199001001-00014
Increased Microvascular Permeability and Lesion Formation During Gastric Hypermotility Caused by Indomethacin and 2‐Deoxy‐D‐Glucose in the Rat
K. Takeuchi (1990)
10.1053/GAST.2002.36558
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
S. Fiorucci (2002)
10.1053/GAST.1996.V111.PM8690211
Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.
S. Kargman (1996)
10.1016/S0016-5085(08)82961-7
Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats.
K. Suzuki (2000)
10.1152/PHYSREV.1999.79.4.1193
Prostanoid receptors: structures, properties, and functions.
S. Narumiya (1999)
10.1159/000200718
Oxygen Free Radicals and Lipid Peroxidation in the Pathogenesis of Gastric Mucosal Lesions Induced by Indomethacin in Rats
K. Takeuchi (1991)
10.1074/jbc.M109.006817
A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions*
Shintaro Suemasu (2009)
10.1152/AJPGI.1997.272.3.G681
Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract.
K. Morimoto (1997)
10.1007/BF01537247
Possible mechanisms involved in gastric hypermotility caused by indomethacin in the rat
K. Takeuchi (2005)
10.1016/S0090-6980(97)00015-4
Distribution of prostaglandin E receptors in the rat gastrointestinal tract.
M. Ding (1997)
10.1136/gut.39.3.363
Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat.
Andrew Anthony (1996)
10.1159/000201341
Diethyldithiocarbamate, a superoxide dismutase inhibitor, reduces indomethacin-induced gastric lesions in rats.
K. Takeuchi (1996)
10.1152/AJPGI.2000.279.4.G791
Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils.
S. Takahashi (2000)
10.1152/AJPGI.1986.250.2.G191
Gastric motility is a major factor in cold restraint-induced lesion formation in rats.
T. Garrick (1986)
Involvement of intracellular Ca 2 + levels in nonsteroidal anti - inflammatory drug - induced apoptosis
C Pal (2005)
cytoprotection: bench to bedside
H Araki (2008)
10.1016/0165-6147(92)90046-9
Pathogenesis of NSAID gastropathy: are neutrophils the culprits?
J. Wallace (1992)
10.1007/BF02779442
Relationship between gastric mucosal hemodynamics and gastric motility
T. Yamaguchi (2007)
10.1016/j.freeradbiomed.2010.04.013
Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis.
Chinmay Pal (2010)
10.1023/A:1018846912032
Effects of Cyclooxygenase-2 Selective and Nitric Oxide-Releasing Nonsteroidal Antiinflammatory Drugs on Mucosal Ulcerogenic and Healing Responses of the Stomach
H. Ukawa (2004)
10.1159/000074518
Both Selective COX-1 and COX-2 Inhibitors Aggravate Gastric Damage Induced in Rats by 2-Deoxy-D-Glucose
K. Takeuchi (2003)
10.1007/BF01972377
Alterations in the gastro-intestinal functions during the development of adjuvant disease in rats
R. Schleyerbach (2005)
10.1016/0014-5793(93)80263-T
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
G. O'neill (1993)
10.1016/S0002-9343(84)80014-5
Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents.
F. Lanza (1984)
10.1016/0262-1746(82)90051-8
Contractile responses of longitudinal and circular smooth muscle of the canine stomach to prostaglandins E and F2alpha.
K. Milenov (1982)
thy: are neutrophils the culprits
Z Morise (1992)
10.1007/BF01540340
Role of prostaglandin deficiency in pathogenetic mechanism of gastric lesions induced by indomethacin in rats
M. Okada (2005)
10.1016/0306-3623(93)90018-S
NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
N. Futaki (1993)
10.1016/0016-5085(95)90065-9
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats.
L. Santucci (1995)
10.1136/gut.35.7.909
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha.
L. Santucci (1994)
10.1152/AJPGI.1982.242.4.G429
Prevention of phenylbutazone ulcer in the rat by glucose: role of a glycoprivic receptor system.
W. Mersereau (1982)
10.1254/JJP.89.1
Alteration of gastric ulcerogenic and healing responses in rats with adjuvant-induced arthritis.
S. Kato (2002)
ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents
JY Wang (1984)
10.1111/j.1365-2362.1990.tb01881.x
Gastric microvascular endothelium: a major target for aspirin‐induced injury and arachidonic acid protection. An ultrastructural analysis in the rat
A. Tarnawski (1990)
10.1159/000051876
Prostaglandin E Inhibits Indomethacin-Induced Gastric Lesions through EP-1 Receptors
K. Suzuki (2001)
10.1111/j.1476-5381.1995.tb15943.x
Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils
R. A. Armstrong (1995)
10.1023/A:1015867119014
Prevention by Parenteral Aspirin of Indomethacin-Induced Gastric Lesions in Rats: Mediation by Salicylic Acid
Y. Komoike (2004)
10.1124/JPET.102.040659
Ulcerogenic Influence of Selective Cyclooxygenase-2 Inhibitors in the Rat Stomach with Adjuvant-Induced Arthritis
S. Kato (2002)
10.1016/0016-5085(90)90464-C
Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions.
P. K. Konturek (1990)
10.5555/uri:pii:0016508581901967
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat.
B. Whittle (1981)
pathogenesis of indomethacin-induced gastric mucosal lesions in rats
Y Mashita (1988)
Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Relation to gastric hypermotility.
K. Takeuchi (1991)
10.1152/AJPGI.1992.262.5.G903
Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products.
H. Asako (1992)
10.1023/B:DDAS.0000017436.05273.fd
Functional Mechanism Underlying COX-2 Expression Following Administration of Indomethacin in Rat Stomachs: Importance of Gastric Hypermotility
K. Takeuchi (2004)
10.1159/000094098
Oral but Not Parenteral Aspirin Upregulates COX-2 Expression in Rat Stomachs
Y. Mashita (2006)
10.1016/S0928-4257(01)00005-5
Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs
A. Tanaka (2001)
10.1016/j.cca.2009.12.026
Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
K. Takeuchi (2010)
10.1007/BF02005762
Neutrophil infiltration does not contribute to the ulcerogenic effects of indomethacin in the rat gastric antrum
M. Trevethick (2005)
10.1046/j.1365-2036.16.s2.22.x
Up‐regulation of COX‐2 by inhibition of COX‐1 in the rat: a key to NSAID‐induced gastric injury
A. Tanaka (2002)



This paper is referenced by
EVALUACION DEL EFECTO GASTROPROTECTOR DEL DHA (ACIDO DOCOSAHEXAENOICO) EN EL DANO GASTRICO INDUCIDO POR INDOMETACINA
Pineda Peña (2013)
Colorectal tubular adenoma bleeding in patients with decompensated cirrhosis-a case report
Zhenglei Xu (2017)
Antiplatelet effects of Angelica dahurica extracts in rat platelets
P. Srisom (2016)
10.1016/j.ejphar.2019.01.044
The relatively selective cyclooxygenase‐2 inhibitor nimesulide: What's going on?
E. Caiazzo (2019)
Protective effects of the chalcone 1-(4-hydroxy-phenyl) -3-m-tolyl-propenone against indomethacin-induced gastric erosive damage in rats.
M. A. Abdulla (2014)
10.21608/besps.2014.34798
Effect Of L-Citrulline And Ranitidine On Indomethacin-Induced Gastric Ulcer In Male Albino Wister Rats
M. El-Saka (2014)
10.1186/s12917-014-0303-7
Protective effects of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone chalcone in indomethacin-induced gastric erosive damage in rats
Summaya M. Dhiyaaldeen (2014)
10.1016/j.jevs.2019.102836
A Botanical-Based Equine Nutraceutical Reduces Gastric Smooth Muscle Contractile Force In Vitro.
Lexie Reed (2020)
10.3389/fphar.2020.00374
Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo
L. Di Francesco (2020)
Effects of policosanol on gastroprotective action of D-002 Efectos del policosanol en la acción gastroprotectora del D-002 Dra
Daisy Carbajal Quintana (2015)
10.1126/scitranslmed.aat7455
Mesenchymal stem cells promote healing of nonsteroidal anti-inflammatory drug-related peptic ulcer through paracrine actions in pigs
Xianfeng Xia (2019)
10.1016/j.jep.2016.10.064
The essential oil from the twigs of Cinnamomum cassia Presl alleviates pain and inflammation in mice.
L. Sun (2016)
10.1016/j.jep.2016.02.051
Anti-inflammatory and antinociceptive activities of Croton urucurana Baillon bark.
Kátia Wolff Cordeiro (2016)
10.1093/schbul/sbt070
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
M. Nitta (2013)
10.1007/978-3-7091-0715-7_21
Peptic Ulcer Disease
P. Konturek (2014)
10.2147/IJN.S247252
Pumpkin Oil–Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats
O. Ahmed (2020)
The Effect of Hydro-Alcoholic Extract of Plantago Major on Indomethacin-Induced Gastric Ulcer in Rats
M. Paseban (2019)
10.1016/j.phytochem.2016.12.002
Gastroprotective effects of hydroethanolic root extract of Arrabidaea brachypoda: Evidences of cytoprotection and isolation of unusual glycosylated polyphenols.
Cláudia Q da Rocha (2017)
10.1016/j.ejphar.2017.05.006
MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice
M. Crowe (2017)
10.1007/s10620-015-4026-9
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility
Z. Zádori (2015)
10.1177/1534735414523315
Dietary Quercetin Reduces Chemotherapy-Induced Fatigue in Mice
S. Mahoney (2014)
10.21215/KJFP.2016.6.5.479
Correlation between Peptic Ulcer Disease and Risk Factors
Joo Won Kang (2016)
10.26717/BJSTR.2018.11.002153
Electroacupuncture Against Ethanol-InducedGastric Ulcer in Rats: Effects on Gastric Contractilityand in the Levels of TNF-α
Aline French de Lima Vitorino (2018)
10.1039/c4fo00711e
Safety and anti-ulcerogenic activity of a novel polyphenol-rich extract of clove buds (Syzygium aromaticum L).
Abin Issac (2015)
10.3109/10253890.2014.967207
Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage
I. Fomenko (2014)
10.1016/S1875-5364(20)30004-2
Mechanistic evaluation of gastro-protective effects of KangFuXinYe on indomethacin-induced gastric damage in rats.
Qi-juan Li (2020)
Ulcer Effect of Methanol Extract of the Root Bark EntandrophragmaAngolense (Meliacaea ) in Rodents
Ebere Emilia Ayogu (2015)
10.1016/j.jep.2019.112350
Protective effects of flavonoid composition rich P. subpeltata Ortega. on indomethacin induced experimental ulcerative colitis in rat models of inflammatory bowel diseases.
S. Shanmugam (2019)
Production sélective et directionnelle des prostaglandines dans l'endomètre
Nicolas Lacroix-Pépin (2014)
10.15550/ASJ.2015.01.036
INFLUENCE OF DICLOFENAC SODIUM ON BIOCHEMICAL INDICATORS OF STOMACH MUCOSA CONDITIONS AGAINST THE BACKGROUND OF EXCESS AND DEFICIENCY OF HYDROGEN SULFIDE IN RATS
Natalia Voloshchuk (2015)
10.1016/j.bbamem.2017.03.009
Neuroprotective effect of 2-hydroxy arachidonic acid in a rat model of transient middle cerebral artery occlusion.
I. F. Ugidos (2017)
10.1016/j.jep.2017.08.007
Hydroalcoholic extract from bark of Persea major (Meisn.) L.E. Kopp (Lauraceae) exerts antiulcer effects in rodents by the strengthening of the gastric protective factors.
Lincon Bordignon Somensi (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar